Seasonal allergic conjunctivitis

Indication for Emadine

Population group: Suitable for both men and women, only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 - 65 years old)

Symptomatic treatment of seasonal allergic conjunctivitis.

For this indication, competent medicine agencies globally authorize below treatments:

2 drops in 2 divided doses daily

Route of admnistration

Ophthalmic

Defined daily dose

2 - 2 {drops}

Dosage regimen

From 1 To 1 {drops} 2 time(s) per day every day

Detailed description

The dose is one drop of emedastine to be applied to the affected eye(s) twice daily.

When used with other ophthalmic medicines, an interval of ten minutes should be allowed between applications of each medicinal product. Eye ointments should be administered last.

Active ingredient

Emedastine is a potent selective and topically effective histamine H1 antagonist. In vivo topical ocular administration of emedastine produces a concentration-dependent inhibition of histamine-stimulated conjunctival vascular permeability.

Read more about Emadine

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner